ENCOMPASS HEALTH CORP (EHC) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:EHC - US29261A1007 - Common Stock
113.02 USD
-0.02 (-0.02%)
113.02 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 87% to EHC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 143.14. This target is 26.65% above the current price.
EHC was analyzed by 17 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about EHC.
In the previous month the buy percentage consensus was at a similar level.
EHC was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-02 | UBS | Maintains | Buy -> Buy |
| 2025-09-16 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-08-06 | UBS | Maintains | Buy -> Buy |
| 2025-06-05 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-05-27 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-28 | UBS | Maintains | Buy -> Buy |
| 2025-04-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-04-25 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-25 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-02-10 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-02-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-30 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-10-29 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-10-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-14 | Truist Securities | Maintains | Buy -> Buy |
| 2024-10-11 | Keybanc | Initiate | Overweight |
| 2024-09-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-09-25 | UBS | Maintains | Buy -> Buy |
| 2024-08-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-08 | UBS | Maintains | Buy -> Buy |
| 2024-08-06 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-08-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-07-10 | Leerink Partners | Initiate | Outperform |
ENCOMPASS HEALTH CORP / EHC FAQ
What is the price target for EHC stock?
17 analysts have analysed EHC and the average price target is 143.14 USD. This implies a price increase of 26.65% is expected in the next year compared to the current price of 113.02.
How do analysts rate ENCOMPASS HEALTH CORP (EHC)?
The consensus rating for ENCOMPASS HEALTH CORP (EHC) is 87.0588 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for EHC stock?
The number of analysts covering ENCOMPASS HEALTH CORP (EHC) is 17.